EDF Health

EDF Statement on House TSCA Reform Discussion Draft

By EDF Blogs / Published: February 28, 2014

In the latest indication of continued engagement toward reform of the Toxic Substances Control Act (TSCA), Rep. John Shimkus (R-IL), Chairman of the Subcommittee on Environment and the Economy of the House Energy and Commerce Committee, has publicly issued a new TSCA reform “discussion draft.”

The announcement of this proposal is a starting line in the House, not the finish.  Our preliminary review of the posted draft has identified very serious concerns that, if not addressed, would fail to fix key flaws in TSCA and would weaken current law.

The discussion draft has a very long way to go to yield a bill that ensures protection of public health.  We hope that Chairman Shimkus’ sharing of his proposed language in draft form – initially with committee Democrats and now with other stakeholders – portends a collaborative bipartisan process that leads to such a bill.

Significant progress has been made through ongoing bipartisan negotiations in the Senate to address key concerns voiced about the Chemical Safety Improvement Act (CSIA, S. 1009) since its introduction last May by the late Senator Frank Lautenberg (D-NJ) and Senator David Vitter (R-LA).

EDF looks forward to engaging with both Republican and Democratic offices and intends to offer proposals to make needed improvements in the discussion draft and move meaningful and effective TSCA reform legislation forward.

Posted in Health policy, TSCA reform / Tagged | Comments are closed

Putting Words Into Action: Walmart releases detailed plans to implement its chemical policy

By EDF Blogs / Published: February 27, 2014

Jennifer McPartland, Ph.D., is a Health Scientist.  Boma Brown-West is a Manager for Consumer Health.

Today, Walmart unveiled its sustainable chemicals policy Implementation Guide. The Guide details how the company will work with suppliers to bring safer products to millions of American shoppers, as announced last September when the policy was introduced.

Walmart’s chemicals policy affects formulated consumable products – the non-food products that you can pour, squeeze, dab or otherwise apply to your body or use in and around your home or car, from health and beauty aids to baby products to pet supplies. There are three main components of the policy:  transparency through expanded ingredient disclosure; advancement of safer product formulation through the reduction, restriction, and elimination  of priority chemicals and use of safer substitution practices; and a plan to take Walmart private brand consumables through the U.S. EPA Design for Environment (DfE) Safer Product Labeling Program — a rigorous product certification program that reviews the safety of product ingredients. Walmart’s policy is audacious in that it attempts to evolve from the common restricted substance list (RSL) approach to one that actively promotes usage of safer chemicals.  The release of the Implementation Guide makes public how this is expected to happen.  Read More »

Posted in Health policy, Markets and Retail / Tagged , , , | Read 2 Responses

Is BPA a carcinogen?

By Sarah Vogel / Published: February 21, 2014

Sarah Vogel, Ph.D., is Director of EDF’s Health Program.

Add liver cancer—a childhood cancer on the rise in the US—to the growing list of potential health effects associated with bisphenol A (BPA) exposure that are under scrutiny by researchers.  A recent study by scientists at the University of Michigan, published in Environmental Health Perspectives, is the first ever to report a dose-dependent, statistically significant relationship between perinatal (before and just after birth) exposures to environmentally relevant levels of BPA and development of cancerous liver tumors later in life.

There are three particularly notable features of this study: first, the dose levels used; second, the timing of when those doses were delivered; and third, the age at which effects were observed.  Read More »

Posted in Emerging science, Health science / Tagged , , | Read 1 Response

Unnerving developments in the state of the evidence on developmental neurotoxicity

By / Published: February 18, 2014

Rachel Shaffer is a research assistant.

Seven years ago, leading children’s environmental health experts Philippe Grandjean and Philip Landrigan published a groundbreaking review that identified five chemicals prevalent in the environment—lead, methylmercury, polychlorinated biphenyls (PCBs), arsenic, and toluene—as developmental neurotoxicants. In their follow-up review released last week, they have added six more chemicals—manganese, fluoride, polybrominated diphenyl ethers (PBDEs), chlorpyrifos, DDT, and tetrachloroethylene (PERC)—to this list. The implications of early-life exposures to these common compounds, say the authors?  A “global silent pandemic of neurodevelopmental toxicity.”  Read More »

Posted in Emerging science, Health policy, Health science / Tagged , , , , , | Read 2 Responses

A full month after West Virginia spill, many questions linger … along with the chemical’s distinctive odor

By / Published: February 9, 2014

Richard Denison, Ph.D., is a Senior Scientist.

Today marks exactly a month since what is now said to be 10,000 gallons of “crude MCHM” – mixed with what was later found to have included other chemicals – spilled into West Virginia’s Elk River, contaminated 1,700 miles of piping in the water distribution system for nine counties, and disrupted the lives of hundreds of thousands of the state’s residents. 

Despite declining levels of the chemical in the water being fed into the distribution system, late this past week five area schools were closed due to detection of the distinctive licorice-like odor of MCHM and multiple reports of symptoms such as eye irritation, nausea and dizziness among students and staff.

The latest sampling data (for February 7 and 8) at locations such as area fire hydrants and hospitals and at schools shows that MCHM is at non-detect levels (<10 parts per billion) in most samples, but the chemical is still being detected in a minority of the samples despite extensive flushing.  Despite repeated calls to do so, officials appear to have yet to conduct any sampling of taps in residents’ homes.

This past week also featured a press conference by state and federal officials seeking to explain their response to the spill (a video of the entire press conference is available in four parts here; it’s worth watching).  [UPDATE 3/29/14:  As this link no longer works, here are updated links to Part 1, Part 2, Part 3 and Part 4 of the press conference.]

Today’s Charleston Gazette features the latest in a long series of outstanding front-line reports by Ken Ward, Jr., and his colleagues, who have closely followed every twist and turn of both the spill and the government’s response to it.  Today’s article makes clear the extent to which federal officials were winging it in the hours and days after the spill was discovered as they rushed to set a “safe” level for MCHM in tap water.

In this post I’ll delve a little deeper into CDC’s rush to set the “safe” level and the many ways in which CDC inadequately accounted for major data gaps and uncertainties.  I’ll end by saying what I think CDC should have done instead.  Read More »

Posted in Environment, Health policy, Health science / Tagged , , | Read 2 Responses

A REACH milestone: First authorisation application passes the European Chemicals Agency

By / Published: February 6, 2014

Alissa Sasso is a Chemicals Policy Fellow.

It’s been a while since we’ve posted an update on ongoing activities under the European Union’s Regulation on the Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH).  The European Chemicals Agency (ECHA) has been quite busy in recent months.

The first application for authorisation (we’ll be using the English spelling of this term, as it is spelled in REACH) to use a Substance of Very High Concern (SVHC) cleared ECHA’s Committees for Risk Assessment (RAC) and Socio-Economic Analysis (SEAC) on January 3rd. This is a significant step in the implementation of REACH in the EU. The authorisation process is intended both to manage the risks posed by SVHCs and to drive the replacement of these hazardous substances with safer alternatives.  And, as the final step in the process laid out under REACH for managing chemical substances, its execution is central to the success of REACH as a whole. This first application for authorisation was therefore a kind of test-run for ECHA, as well as the chemical industry, and sets the stage for the submission and review of future authorisation applications.

As we run through the details of this particular authorisation application, keep in mind that ECHA received seven other applications for authorisation last year, and will see even more activity in the coming year.  Read More »

Posted in Health policy / Tagged , , , | Comments are closed